TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22280120

Group type: EXPERIMENTAL
Intervention: Wearing facemasks and practicing intensified hand hygiene (MH group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Wearing facemasks only (M group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study: 20598667

Group type: EXPERIMENTAL
Intervention: 0.3 mg intravitreal ranibizumab
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 0.5 mg intravitreal ranibizumab
Number of subjects: 184

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 184

Group type: COMPARATOR
Intervention: Sham group patients who crossed over to 0.5 mg ranibizumab
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 0.3 mg ranibizumab after rollover to monthly dosing
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab after rollover to monthly dosing
Number of subjects: 184
Study: 16767731

Group type: EXPERIMENTAL
Intervention: TGF-beta(2) enriched feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (not enriched) feeding
Number of subjects: 0
Study: 16368446

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg QD AM
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg QD PM
Number of subjects: 405

Group type: COMPARATOR
Intervention: Budesonide 200 microg BID
Number of subjects: 405
Study: 12196219

Group type: EXPERIMENTAL
Intervention: One-visit treatment with gutta-percha and AH-26 sealer
Number of subjects: 39

Group type: COMPARATOR
Intervention: Two-visit treatment with calcium hydroxide for 4 weeks followed by gutta-percha and AH-26 sealer
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Positive root-canal culture at the time of obturation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Positive bacterial culture (CFU<10(2)) at the time of filling
Number of subjects: 39
Study: 9638715

Group type: EXPERIMENTAL
Intervention: 10 g of mannitol
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 20 g of mannitol
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 30 g of mannitol
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no mannitol)
Number of subjects: 76
Study: 7668437

Group type: EXPERIMENTAL
Intervention: Hotline fluid warmer
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group without warner
Number of subjects: 42
Study: 2574051

Group type: COMPARATOR
Intervention: SK&F 101468 (doses between 80 micrograms and 2.5 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SK&F 101468 (up to 1 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31061252

Group type: EXPERIMENTAL
Intervention: Ultrasonography during hemodialysis sessions
Number of subjects: 7

Group type: COMPARATOR
Intervention: X-ray before evaluation by US
Number of subjects: 7
Study: 28363923

Group type: EXPERIMENTAL
Intervention: Web-based pulmonary rehabilitation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional pulmonary rehabilitation
Number of subjects: 103
Study: 26314532

Group type: EXPERIMENTAL
Intervention: Post-discharge bleeding (PDB)
Number of subjects: 8582

Group type: EXPERIMENTAL
Intervention: Post-discharge myocardial infarction (PDMI)
Number of subjects: 8582
Study: 23207247

Group type: EXPERIMENTAL
Intervention: Anterior 180-degree partial fundoplication
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 18
Study: 21636245

Group type: EXPERIMENTAL
Intervention: High social anxiety individuals
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Low social anxiety individuals with low experiential avoidance (EA)
Number of subjects: 170
Study: 19149939

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH) 12 IU/d
Number of subjects: 30

Group type: COMPARATOR
Intervention: isotonic saline
Number of subjects: 30
Study: 16522836

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14656841

Group type: EXPERIMENTAL
Intervention: Penicillin for seven days
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Penicillin for three days followed by placebo for four days
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo for seven days
Number of subjects: 156

Group type: COMPARATOR
Intervention: Penicillin (both regimens) vs Placebo
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Penicillin treatment
Number of subjects: 156
Study: 11138573

Group type: EXPERIMENTAL
Intervention: Stress condition
Number of subjects: 11

Group type: COMPARATOR
Intervention: Relaxation condition
Number of subjects: 11
Study: 9177418

Group type: EXPERIMENTAL
Intervention: Carbimazole plus low dose CT (Calsynar; 100 IU/day, 2 days/week)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Carbimazole plus high dose CT (Calsynar; 100 IU/day, 14 days/month)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Carbimazole (Neotomizol)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nasal calcitonin (CT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 45
Study: 8426767

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for upper respiratory infections
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no antibiotic treatment)
Number of subjects: 0
Study: 3429867

Group type: EXPERIMENTAL
Intervention: AII/NA infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dextrose/NA infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All/saline infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dextrose/saline infusion
Number of subjects: 10
Study: 30243962

Group type: EXPERIMENTAL
Intervention: TR band (TRG)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Safeguard Radial (SGG)
Number of subjects: 320
Study: 25989426

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) combined with physical activity
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard hypolypemic diet (SHD) with physical activity
Number of subjects: 124
Study: 25552280

Group type: EXPERIMENTAL
Intervention: Re‐feeding group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Fresh‐feeding group
Number of subjects: 72
Study: 23961701

Group type: COMPARATOR
Intervention: Implementation strategies used in children's social service organizations
Number of subjects: 7

Group type: COMPARATOR
Intervention: Web-based survey assessing perceived effectiveness, relative importance, acceptability, feasibility, and appropriateness of implementation strategies
Number of subjects: 7

Group type: COMPARATOR
Intervention: Organizational Social Context measure
Number of subjects: 7
Study: 21867385

Group type: EXPERIMENTAL
Intervention: Beliefs that Alzheimer's disease can be prevented
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Beliefs that Alzheimer's disease is preventable
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Engagement in behaviors to prevent Alzheimer's disease
Number of subjects: 139

Group type: COMPARATOR
Intervention: Manipulation of beliefs about AD preventability
Number of subjects: 139
Study: 19325202

Group type: EXPERIMENTAL
Intervention: Test dentifrice containing nano-sized calcium carbonate (NC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo dentifrice without NC
Number of subjects: 0
Study: 17003850

Group type: EXPERIMENTAL
Intervention: 2 mg exogenous melatonin orally
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 mg exogenous melatonin orally + CYP2C19 substrate
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo + CYP2C19 substrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: melatonin treatment
Number of subjects: 15
Study: 15486168

Group type: EXPERIMENTAL
Intervention: Authentic CBTI reports
Number of subjects: 41

Group type: COMPARATOR
Intervention: Modal CBTI reports
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Automated Assessment Associates' report
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Western Psychological Services, Pearson Assessments, Caldwell Report
Number of subjects: 41
Study: 11277319

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 480 mg/day during RT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9079231

Group type: EXPERIMENTAL
Intervention: NTG oral spray (Myocor Spray)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sublingual tablet
Number of subjects: 17
Study: 8421422

Group type: EXPERIMENTAL
Intervention: Three courses of cis-platinum containing chemotherapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard treatment of surgery and postoperative radiotherapy
Number of subjects: 112
Study: 3784136

Group type: EXPERIMENTAL
Intervention: Topical forskolin (50 microliter of 1% forskolin)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical forskolin (two instillations)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical 0.25% 1-timolol (pretreatment)
Number of subjects: 20
Study: 30112725

Group type: EXPERIMENTAL
Intervention: DFN-11 (3 mg sumatriptan injection)
Number of subjects: 234
Study: 27502706

Group type: EXPERIMENTAL
Intervention: RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consensus-based treatment
Number of subjects: 0
Study: 24819570

Group type: EXPERIMENTAL
Intervention: Low-literacy, primary-care intervention using an interactive educational toolkit and clinician-centered curriculum for obesity prevention.
Number of subjects: 865

Group type: COMPARATOR
Intervention: Attention-control arm implementing the American Academy of Pediatrics' The Injury Prevention Program.
Number of subjects: 865
Study: 23045660

Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Never-Institutionalized Group (NIG)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Care As Usual Group (CAUG)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG) placed after 20 months
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Electroencephalogram alpha power
Number of subjects: 3
Study: 20156980

Group type: EXPERIMENTAL
Intervention: Errorless learning intervention (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as usual control (n = 15)
Number of subjects: 30
Study: 18551027

Group type: EXPERIMENTAL
Intervention: Ramipril treatment group
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1008
Study: 16334717

Group type: EXPERIMENTAL
Intervention: External application of Chinese drugs on acupoint Shenque (CV 8) combined with salpingostomy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Salpingostomy only
Number of subjects: 75
Study: 12888366

Group type: EXPERIMENTAL
Intervention: Goserelin (Zoladex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CMF chemotherapy
Number of subjects: 0
Study: 10389801

Group type: EXPERIMENTAL
Intervention: Air-filled endotracheal cuff inflated to 30-40 cm H2O
Number of subjects: 65

Group type: COMPARATOR
Intervention: Gas mixture (N2O 50% in oxygen)
Number of subjects: 65
Study: 8545199

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal, n = 644)
Number of subjects: 1296

Group type: COMPARATOR
Intervention: Modified bovine surfactant extract (Survanta, n = 652)
Number of subjects: 1296

Group type: COMPARATOR
Intervention: Modified bovine surfactant extract (Survanta)
Number of subjects: 1296
Study: 8469318

Group type: EXPERIMENTAL
Intervention: 1.6 million international units (MIU) of IFNB
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: 8 MIU of IFNB
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 3885963

Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg capsules
Number of subjects: 52

Group type: COMPARATOR
Intervention: Pentazocine 50 mg capsules
Number of subjects: 52
Study: 29550015

Group type: EXPERIMENTAL
Intervention: Cardiac Magnetic Resonance (CMR) evaluation
Number of subjects: 0
Study: 27780772

Group type: EXPERIMENTAL
Intervention: ERAS program with extended stoma education (n=61)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard care with current stoma education (n=61)
Number of subjects: 122
Study: 25543606

Group type: EXPERIMENTAL
Intervention: Fixed Twin-block combined with fixed appliance
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fixed appliance after tooth extraction
Number of subjects: 31
Study: 22424890

Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Low-density negative ion generator
Number of subjects: 44

Group type: COMPARATOR
Intervention: High-density negative ion generator
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Adverse events assessed using Young Mania Rating Scale (YMRS) and Systematic Assessment for Treatment Emergent effects (SAFTEE)
Number of subjects: 44
Study: 20439846

Group type: EXPERIMENTAL
Intervention: 150 mg of mexiletine 3 times daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 200 mg of mexiletine 3 times daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17869557

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 15 min before, during and following heel prick (n=31)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular care (n=28)
Number of subjects: 59
Study: 16012932

Group type: EXPERIMENTAL
Intervention: Colonoscopic surveillance
Number of subjects: 2915
Study: 12424317

Group type: EXPERIMENTAL
Intervention: Training to improve contour detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colinear alignment of nearby segments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short contour spacing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermediate spacing with colinear lines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spacing beyond critical range (about 2 degrees)
Number of subjects: 0
Study: 10491235

Group type: EXPERIMENTAL
Intervention: Return visits
Number of subjects: 212

Group type: COMPARATOR
Intervention: Initial visits
Number of subjects: 212
Study: 8735678

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg)
Number of subjects: 16
Study: 1913227

Group type: EXPERIMENTAL
Intervention: FEC (fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 60

Group type: COMPARATOR
Intervention: FNC (fluorouracil, mitoxantrone, and cyclophosphamide)
Number of subjects: 60
Study: 6092982

Group type: EXPERIMENTAL
Intervention: LoNaHCO3 dialysis (sodium bicarbonate, Na = 134, HCO3 = 33 mEq/l)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HiNaAc dialysis (high sodium acetate, Na = 144, acetate = 33 mEq/l)
Number of subjects: 6

Group type: COMPARATOR
Intervention: LoNaAc dialysis (sodium acetate, Na = 134, acetate = 33 mEq/l)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: LoNaHCO3 dialysis
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HiNaAc dialysis
Number of subjects: 6
Study: 29664328

Group type: EXPERIMENTAL
Intervention: Social reference
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Advertisement
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Attitude toward the system
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Access to cellphone
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Perceived system effectiveness
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Demographic variables (age, gender, education)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Monthly family expenditure
Number of subjects: 292
Study: 30286130

Group type: EXPERIMENTAL
Intervention: SST training plus standard rehabilitation program
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard rehabilitation program (Control)
Number of subjects: 75
Study: 27814860

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 32
Study: 24725198

Group type: EXPERIMENTAL
Intervention: SGA Disc Group (discontinued risperidone)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Risp Cont Group (continued risperidone)
Number of subjects: 101

Group type: COMPARATOR
Intervention: SGA Cont Group (switched to another SGA)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Change in BMI z score
Number of subjects: 101
Study: 22345126

Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg/day
Number of subjects: 476

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study: 20149752

Group type: EXPERIMENTAL
Intervention: Interactive multimedia (IMM) food safety education program on a computer kiosk
Number of subjects: 176
Study: 17365885

Group type: EXPERIMENTAL
Intervention: C-leg microprocessor-controlled prosthetic knee
Number of subjects: 13

Group type: COMPARATOR
Intervention: Non-microprocessor control (NMC) prosthetic knees
Number of subjects: 13
Study: 15625424

Group type: EXPERIMENTAL
Intervention: Infant formula with 0.8 g/100 ml GOS/FOS (OSF group)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control formula (SF group)
Number of subjects: 2
Study: 12045365

Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 9656585

Group type: EXPERIMENTAL
Intervention: 1 ml of iodised oil (Lipiodol®) administered orally in Namentenga
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: 1 ml of iodised oil (Lipiodol®) administered IM in Passore
Number of subjects: 423
Study: 7893024

Group type: EXPERIMENTAL
Intervention: Bupivacaine (1 mg/kg of 0.5% bupivacaine with epinephrine 1:200000 in 20 mL of saline 0.9%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine (3 mg/kg of 2% lidocaine with epinephrine in 20 mL of saline 0.9%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (20 mL of saline 0.9%)
Number of subjects: 0
Study: 2505216

Group type: EXPERIMENTAL
Intervention: 80 mg tobramycin solution, inhaled 3 times daily (15 patients)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 2 mL saline, inhaled 3 times daily (12 patients)
Number of subjects: 27
Study: 11284

Group type: EXPERIMENTAL
Intervention: Group I (normal labor with spontaneous rupture of membranes)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Group II (labor with artificial rupture of membranes)
Number of subjects: 38
Study: 31056373

Group type: EXPERIMENTAL
Intervention: Chemical foot warmers applied to handheld ultrasound machines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no chemical foot warmers)
Number of subjects: 0
Study: 28281433

Group type: EXPERIMENTAL
Intervention: Operative laparoscopy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 140
Study: 25153922

Group type: EXPERIMENTAL
Intervention: Cane fitted to the greater trochanter (GT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cane fitted to the wrist crease (WC)
Number of subjects: 16
Study: 23859894

Group type: EXPERIMENTAL
Intervention: Gradual Decompression (GD)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Rapid Decompression (RD)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Both GD and RD
Number of subjects: 294
Study: 21810191

Group type: EXPERIMENTAL
Intervention: Niacin (up to 1,500 mg daily for 12 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Niacin (for moderate ED)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Niacin (for severe ED)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (for severe ED)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (for moderate ED)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Niacin (for patients not receiving statins)
Number of subjects: 160
Study: 19472972

Group type: EXPERIMENTAL
Intervention: Sequential bilateral TKA under 1 anesthetic
Number of subjects: 70

Group type: COMPARATOR
Intervention: Unilateral TKA
Number of subjects: 70
Study: 17491170

Group type: EXPERIMENTAL
Intervention: Internet smoking cessation service (www.QuitNet.com)
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Internet smoking cessation service (www.QuitNet.com) with telephone counseling
Number of subjects: 764

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 764
Study: 15028366

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation and exercise training for three months
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (did not attend cardiac rehabilitation)
Number of subjects: 277
Study: 11354235

Group type: COMPARATOR
Intervention: 50 mg of sertraline
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 150 mg of sertraline
Number of subjects: 91
Study: 9442548

Group type: EXPERIMENTAL
Intervention: Sulpiride (200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7970587

Group type: EXPERIMENTAL
Intervention: Anterior lateral surgical approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medial surgical approach
Number of subjects: 40
Study: 3107808

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Enteral Feeding Program
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN) and Enteral Feeding Program
Number of subjects: 57
Study: 31918704

Group type: EXPERIMENTAL
Intervention: Mobile health intervention (interactive voice call and call center)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 18
Study: 29609566

Group type: EXPERIMENTAL
Intervention: Regular pulsatile cupping with 8 treatments plus paracetamol on demand (n=37)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Minimal cupping with 8 treatments plus paracetamol on demand (n=36)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group with paracetamol on demand only (n=37)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Regular pulsatile cupping
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Minimal cupping
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Paracetamol intake
Number of subjects: 110
Study: 26105516

Group type: EXPERIMENTAL
Intervention: Amino acid jelly Inner Power(®) (IP) once daily for 21 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 59
Study: 25532503

Group type: EXPERIMENTAL
Intervention: Lafutidine (20 mg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Famotidine (40 mg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg)
Number of subjects: 144